Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Treasury Shares (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Treasury Shares data on record, last reported at $353743.0 in Q4 2025.

  • For Q4 2025, Treasury Shares rose 24.14% year-over-year to $353743.0; the TTM value through Dec 2025 reached $353743.0, up 24.14%, while the annual FY2025 figure was $353743.0, 24.14% up from the prior year.
  • Treasury Shares reached $353743.0 in Q4 2025 per MIRM's latest filing, roughly flat from $353743.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $353743.0 in Q1 2025 and bottomed at $22270.0 in Q3 2022.
  • Average Treasury Shares over 5 years is $218862.3, with a median of $222660.0 recorded in 2021.
  • Peak YoY movement for Treasury Shares: tumbled 85.71% in 2022, then soared 120.92% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $122464.0 in 2021, then plummeted by 81.82% to $22270.0 in 2022, then soared by 563.83% to $147835.0 in 2023, then surged by 92.75% to $284955.0 in 2024, then grew by 24.14% to $353743.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $353743.0 in Q4 2025, $353743.0 in Q3 2025, and $353743.0 in Q2 2025.